Yuanli Chen Selected Research

Neoplasms (Cancer)

4/2024	Activation of CTU2 expression by LXR promotes the development of hepatocellular carcinoma.
1/2024	TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
1/2024	CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway.
12/2023	Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity.
10/2023	Novel pterostilbene derivatives ameliorate heart failure by reducing oxidative stress and inflammation through regulating Nrf2/NF-κB signaling pathway.
12/2021	[Advances in the structure and physiological function of protein kinase CK2].
1/2021	Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis.
1/2019	Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.
12/2018	CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells.
10/2018	Inhibition of Vascular Calcification.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanli Chen Research Topics

Disease

34	Atherosclerosis 12/2023 - 06/2012
22	Inflammation (Inflammations) 12/2023 - 04/2014
13	Neoplasms (Cancer) 04/2024 - 06/2013
8	Insulin Resistance 12/2023 - 01/2019
8	Fatty Liver 01/2022 - 01/2018
7	Vascular Calcification 03/2024 - 10/2018
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2015
6	Breast Neoplasms (Breast Cancer) 04/2024 - 05/2015
6	Non-alcoholic Fatty Liver Disease 12/2023 - 02/2018
5	Sepsis (Septicemia) 10/2023 - 01/2016
5	Heart Failure 10/2023 - 03/2020
4	Neuroinflammatory Diseases 09/2023 - 05/2020
4	Cholestasis 01/2023 - 01/2019
4	Hypertriglyceridemia 01/2023 - 04/2015
4	Fibrosis (Cirrhosis) 04/2022 - 11/2019
4	Lung Injury 01/2022 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2014
4	Coronary Disease (Coronary Heart Disease) 01/2017 - 05/2014
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2023 - 01/2022
3	Necrosis 01/2023 - 11/2019
3	Hyperlipidemias (Hyperlipidemia) 01/2023 - 12/2018
3	Hypercholesterolemia 01/2023 - 01/2017
3	Obesity 01/2022 - 01/2020
3	Osteoradionecrosis 12/2021 - 01/2015
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 01/2018
3	Vascular Diseases (Vascular Disease) 03/2020 - 01/2019
3	Dyslipidemias (Dyslipidemia) 01/2020 - 04/2015
2	Hypoxia (Hypoxemia) 01/2022 - 01/2022
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2020
2	Atrophy 03/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 11/2019

Drug/Important Bio-Agent (IBA)

18	Apolipoproteins E (ApoE)IBA 01/2023 - 04/2015
16	LipidsIBA 01/2024 - 06/2013
10	LigandsIBA 04/2024 - 12/2012
9	Liver X ReceptorsIBA 01/2021 - 12/2012
9	Capsules (Microcapsules)IBA 01/2021 - 01/2015
8	CholesterolIBA 12/2023 - 12/2012
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2018
7	T0901317IBA 01/2021 - 04/2014
7	naoxintongIBA 01/2021 - 01/2015
6	CytokinesIBA 10/2023 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 06/2015
5	Therapeutic UsesIBA 03/2024 - 01/2019
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 03/2020
5	Rosiglitazone (Avandia)FDA Link 01/2023 - 11/2019
5	ApolipoproteinsIBA 01/2023 - 05/2014
5	U 0126 (UO 126)IBA 01/2022 - 02/2015
5	Transcription Factors (Transcription Factor)IBA 06/2021 - 12/2012
5	CollagenIBA 03/2021 - 05/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2021
4	Fenofibrate (CiL)FDA LinkGeneric 12/2023 - 01/2019
4	AntioxidantsIBA 10/2023 - 09/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 03/2020
4	InterferonsIBA 01/2022 - 02/2015
4	LongShengZhiIBA 03/2020 - 01/2019
4	oxidized low density lipoproteinIBA 01/2020 - 12/2012
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2023 - 12/2020
3	InflammasomesIBA 10/2023 - 01/2016
3	AdiponectinIBA 01/2023 - 01/2017
3	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2019
3	IsoflavonesIBA 09/2022 - 01/2019
3	Adenosine Monophosphate (AMP)IBA 01/2022 - 02/2018
3	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2018
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2020
3	Collagen Type I (Type I Collagen)IBA 03/2021 - 11/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 11/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021 - 11/2019
3	Tamoxifen FDA LinkGeneric 12/2018 - 05/2015
3	trioctyl phosphine oxide (TOPO)IBA 12/2018 - 06/2013
3	Teniposide (VM 26)FDA Link 12/2018 - 06/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018 - 08/2015
3	buchang naoxintongIBA 01/2017 - 01/2015
3	Fatty Acid-Binding ProteinsIBA 08/2015 - 06/2012
2	EnzymesIBA 04/2024 - 03/2020
2	CateninsIBA 03/2024 - 07/2023
2	pitavastatin (itavastatin)FDA Link 01/2024 - 08/2015
2	KetonesIBA 12/2023 - 09/2022
2	pterostilbeneIBA 12/2023 - 10/2023
2	AMP-Activated Protein KinasesIBA 01/2023 - 01/2018
2	Sirtuin 3IBA 09/2022 - 03/2020
2	Pentoxifylline (Trental)FDA LinkGeneric 12/2021 - 01/2020
2	Vitamin E FDA LinkGeneric 12/2021 - 01/2020
2	Toll-Like Receptor 4IBA 03/2021 - 01/2021
2	Glutathione PeroxidaseIBA 03/2021 - 01/2020
2	CatalaseIBA 03/2021 - 03/2020
2	HydrogelsIBA 01/2021 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2021 - 12/2020
2	Urethane (Ethyl Carbamate)IBA 01/2021 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2019
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 05/2014
2	asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamideIBA 12/2020 - 01/2017

Therapy/Procedure

10	Therapeutics 12/2023 - 04/2015
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 01/2018
3	Ligation 11/2019 - 01/2016
2	Immunotherapy 01/2024 - 01/2023
2	Oral Administration 01/2021 - 01/2021